NCT02262975View on ClinicalTrials.gov

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

CompletedOBSERVATIONAL

Enrollment

532

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Alzheimer's Disease

Trial Locations (26)

Unknown

Beijing

Gangwon

Hong Kong

Nanjing

Shaanxi

Shanghai

Manila

Singapore

Busan

Daegu

Daejeon

Gyeonggi-do

Incheon

Jeonju

Kangwon

Seongnam

Seoul

Bangkok

Changhua

Kaohsiung City

New Taipei City

Taichung

Tainan City

Taipei

Bangkok

Shanghai

All Listed Sponsors

lead

Eisai Korea Inc.

INDUSTRY

NCT02262975 - A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS) | Biotech Hunter | Biotech Hunter